Moderna (MRNA) Reports First Shipment of mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Moderna (MRNA) Tops Q4 EPS by 5c
February 26, 2020 7:16 AM ESTModerna (NASDAQ: MRNA) reported Q4 EPS of ($0.37), $0.05 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $14.06 million versus the consensus estimate of $17.37 million.
The Moderna team continues to execute our strategy, including our CMV Phase 2 study enrolling ahead of plan,... More
Moderna (MRNA) Extends Gain, Up 30%
February 25, 2020 2:47 PM ESTModerna (NASDAQ: MRNA) Extends Gain, Up 30%
... MoreModerna (MRNA) calls active into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study
February 25, 2020 5:15 AM ESTModerna (NASDAQ: MRNA) 30 option implied volatility is at 87; compared to its 52-week range of 51 to 99 into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study. Call put ratio 6 calls to 1 put.
... MoreAfter-Hours Stock Movers 02/24: (MRNA) (MMSI) (NLS) Higher; (PANW) (EVER) (SHAK) Lower (more...)
February 24, 2020 5:57 PM ESTToday's After-Hours Stock Movers
Moderna (NASDAQ: MRNA) 14.7% HIGHER; shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests, according to Dow Jones.
Palo Alto Networks (NYSE: PANW) 14.2% LOWER; reported Q2 EPS of $1.19, $0.07 better than the analyst estimate of $1.12. Revenue for the quarter came in at $816.7 million versus the consensus estimate of $843.26 million. Palo Alto Networks sees Q3 2020 EPS of $0.96-$0.98, versus the consensus of $1.25. Palo Alto Networks... More
Moderna (MRNA) Surges 15% After Shipping First Batch of Coronavirus Vaccine for Testing
February 24, 2020 5:34 PM ESTModerna (NASDAQ: MRNA) gains 15% after-hours following reports from Dow Jones the company shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests.
... MoreModerna (MRNA) Delivers First Coronavirus Vaccine for Human Testing - DJ
February 24, 2020 4:46 PM ESTModerna (NASDAQ: MRNA) shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests, according to Dow Jones.
